U.K. investment firm snaps up Israeli start-up Algatechnologies
Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging.
Kibbutz Ketura scored its second exit in three years this weekend when Britain's Grovepoint Capital agreed to buy control of its biotech start-up Algatechnologies.
register with haaretz
Like us on Facebook and get articles directly in your news feed